Lead Product(s) : Psyllium
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Psyllium on Niacin Tolerability
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 12, 2017
Lead Product(s) : Psyllium
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Psyllium
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Taste and Palatability in Fiber Supplements
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 16, 2016
Lead Product(s) : Psyllium
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Psyllium
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Dr. Falk Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Mucofalk
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 20, 2013
Lead Product(s) : Psyllium
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Dr. Falk Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Psyllium
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 20, 2012
Lead Product(s) : Psyllium
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Psyllium
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Duke University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 09, 2012
Lead Product(s) : Psyllium
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Duke University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
